CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2800876&ei=knKaUrDjLa210AHc1AE&usg=AFQjCNH_TaCa_s8XesOekwOSeaG9-8E1gA
Celgene Corp Raises FY 2013 Guidance
Thursday, 25 Jul 2013 07:33am EDT
Celgene Corp announced that for fiscal 2013, it raises adjusted diluted EPS guidance to a range of $5.80-$5.90 from the previous range of $5.55 to $5.65, an increase of approximately 19% over fiscal 2012 adjusted diluted EPS. GAAP diluted EPS is expected to be in the range of $4.17-$4.31 which includes upfront payment expense for collaborations. The Net Product Sales guidance is raised to a range of $4.2-$4.3 billion, from the previous range of $4.1-$4.2 billion, an increase of approximately 13% over fiscal 2012 REVLIMID Net Product Sales. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $4.57 for fiscal 2013.Â 
